In India, people are becoming more conscious of diabetes and its consequences. Healthcare organizations' increased use of awareness campaigns, educational initiatives, and programs helps people understand the value of taking preventive steps, such as wearing diabetic footwear. Doctors' and podiatrists' recommendations are among the most important sources of information influencing customer decisions. The Bureau of Indian Standards (BIS) plays a pivotal role in establishing quality standards for footwear in India, encompassing critical elements such as materials, construction techniques, and labeling practices. Although these standards are not explicitly tailored for diabetic footwear, they serve as a foundation for ensuring fundamental quality and safety benchmarks across the industry. Quality Control Orders (QCOs) mandated by the Indian government necessitate BIS licenses for diverse footwear categories. This regulatory framework has the potential to enforce more rigorous quality control measures, potentially exerting an impact on the production standards of diabetic footwear in the foreseeable future. The Indian Footwear, Leather, and Accessories Development Programme (IFLADP) was introduced by the Indian government in 2021. The goal of this program is to stimulate the leather and footwear industries, particularly the creation of specialized footwear for people with diabetes. An increased risk of diabetes is frequently a result of urbanization and lifestyle modifications. People who live in cities could know more about the latest developments in healthcare and have easier access to specialty goods like diabetic shoes.
According to the research report, "India Diabetic Footwear Market Overview, 2031," published by Bonafide Research, the India Diabetic Footwear market is anticipated to grow at more than 8.79% CAGR from 2026 to 2031.With the significance of foot care in the management of diabetes, the Indian healthcare system is moving toward preventive interventions. This raises awareness of the importance of wearing appropriate footwear when managing the illness. Pressure-mapping insoles and temperature-regulating shoes are just two examples of the cutting-edge innovations that Indian manufacturers are producing and making more widely available at more reasonable pricing points. This broadens the market and offers practical answers to a range of requirements. Programs like the IFLADP are designed to stimulate the leather and shoe sector, which may result in more research and development, production, and reasonably priced diabetic footwear in India. The market is starting to address more specialized demands, such as bigger toe boxes for deformities, features specifically targeted at neuropathy, and post-operative care, rather than just general alternatives. This increases the customer base and serves a variety of demographics. The market in India for diabetic footwear is diverse and has a bright future. A growing market is facilitated by rising consumer knowledge, technical improvements, affordability, government assistance, and shifting customer tastes. Through the resolution of accessibility issues, the expansion of available choices, and the encouragement of user education, the Indian diabetic footwear market may sustainably offer practical solutions to people with diabetes and enhance their general foot health and well-being.
In India’s diabetic footwear market, product preferences reflect a blend of clinical necessity, cultural habits, and climatic influences. Among the various categories, sandals currently hold a leading position, driven by their practicality, comfort in warm weather, and suitability for everyday use in both urban and rural settings. According to industry analysis, sandals accounted for the largest share of the product segment in India around 2024 and are expected to remain the key growth driver in the coming decade, registering the fastest compound annual growth rate as diabetic patients increasingly prioritize breathable footwear that reduces heat stress and prevents moisture buildup all crucial to minimizing foot complications like blisters and ulcers. While sandals reign supreme, diabetic shoes remain highly significant because they offer full coverage protection, structural support, and adaptability to custom orthopedic insoles, making them the preferred choice for more advanced conditions such as neuropathy, deformities, or history of ulcers. Traditional shoes also serve those with more sedentary lifestyles or formal work environments, where closed footwear is common. Slippers play a growing yet secondary role, especially indoors, because modern designs now include arch support and cushioned soles that improve comfort for elderly patients or those needing preventive daily wear outside formal settings. Specialized diabetic socks or others complement these products by offering moisture wicking, cushioning, and friction reduction, providing added protection and comfort when paired with shoes or sandals.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample
We are friendly and approachable, give us a call.